Loading…
GPT Healthcare (GPTHEALTH)₹145.13−1.73%Hospital
In the Jun 2026 quarter (standalone), GPT Healthcare reported sales of ₹125 Cr, up 17.7% from Jun 2025, and net profit of ₹12.97 Cr, up 62.5% year on year. For the year to Mar 2026, sales were ₹471 Cr and net profit ₹41.92 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108 | 96.63 | 98.63 | 97.58 | 106 | 102 | 101 | 107 | 119 | 120 | 126 | 125 |
| Expenses | 82.99 | 75.97 | 76.02 | 79.95 | 81.92 | 81.01 | 81.01 | 89.91 | 96.02 | 99.02 | 103 | 102 |
| Operating Profit | 24.90 | 20.91 | 22.93 | 17.94 | 22.91 | 20.93 | 20.91 | 16.94 | 22.92 | 20.94 | 22.93 | 23.91 |
| OPM % | 23.0% | 22.0% | 22.9% | 17.9% | 21.9% | 20.9% | 19.9% | 15.9% | 18.9% | 17.0% | 17.9% | 18.9% |
| Other Income | 1.01 | 1.01 | 2.01 | 2.01 | 3.01 | 2.01 | 2.01 | 2.01 | 1.01 | 1.01 | 2.01 | 2.01 |
| Interest | 1.99 | 1.99 | 1.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| Depreciation | 3.99 | 3.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 5.99 | 6.99 | 6.99 | 6.98 | 6.99 |
| Profit before tax | 18.94 | 15.95 | 17.95 | 14.97 | 20.95 | 17.95 | 15.96 | 10.96 | 14.95 | 12.96 | 15.95 | 16.94 |
| Tax % | 31.0% | 28.0% | 30.0% | 32.0% | 28.0% | 30.0% | 21.0% | 31.0% | 30.0% | 27.0% | 8.0% | 26.0% |
| Net Profit | 13.97 | 10.99 | 12.97 | 9.98 | 14.96 | 11.98 | 12.99 | 7.98 | 10.97 | 8.99 | 14.97 | 12.97 |
| EPS (Rs) | 1.70 | 1.45 | 1.57 | 1.22 | 1.82 | 1.50 | 1.58 | 0.95 | 1.30 | 1.15 | 1.79 | 1.56 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 211 | 242 | 336 | 359 | 399 | 406 | 471 | 489 |
| Expenses | 176 | 194 | 263 | 287 | 312 | 324 | 387 | 400 |
| Operating Profit | 35.86 | 48.83 | 73.78 | 73.66 | 87.73 | 82.63 | 84.74 | 90.70 |
| OPM % | 16.9% | 20.0% | 22.0% | 20.9% | 21.9% | 19.9% | 17.9% | 18.6% |
| Other Income | 4.01 | 6.01 | 5.01 | 6.01 | 5.01 | 8.01 | 5.01 | 6.04 |
| Interest | 13.99 | 13.99 | 10.99 | 8.99 | 6.99 | 2.99 | 7.99 | 7.96 |
| Depreciation | 10.98 | 11.98 | 13.96 | 14.97 | 17.98 | 18.97 | 26.94 | 27.95 |
| Profit before tax | 14.95 | 28.93 | 53.80 | 55.82 | 67.80 | 68.82 | 54.84 | 60.80 |
| Tax % | 26.0% | 27.0% | 23.0% | 30.0% | 30.0% | 28.0% | 23.0% | — |
| Exceptional items | −0.13 | 0.46 | 0.06 | 0.34 | −0.07 | 0.45 | −0.86 | — |
| Net Profit | 10.97 | 20.95 | 41.92 | 38.94 | 47.88 | 49.95 | 41.92 | 47.90 |
| EPS (Rs) | 6.12 | 11.78 | 5.22 | 4.89 | 5.83 | 6.09 | 5.16 | 5.80 |
| Dividend payout % | 0.0% | 47.0% | 0.0% | 102.0% | 60.0% | 41.0% | 49.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 18.01 | 18.01 | 80.01 | 80.02 | 82.01 | 82.01 | 81.96 |
| Reserves | 109 | 116 | 78.27 | 85.18 | 136 | 167 | 187 |
| Borrowings | 157 | 166 | 102 | 82.07 | 31.02 | 35.04 | 91.05 |
| Other Liabilities | 25.12 | 17.99 | 63.30 | 79.35 | 96.29 | 101 | 104 |
| Total Liabilities | 309 | 317 | 324 | 328 | 347 | 384 | 466 |
| Fixed Assets | 226 | 220 | 220 | 228 | 224 | 228 | 342 |
| CWIP | 1.99 | 0.00 | 0.99 | 2.99 | 5.99 | 45.88 | 0.99 |
| Investments | 1.01 | 1.01 | 10.04 | 13.05 | 30.11 | 32.13 | 43.17 |
| Other Assets | 80.15 | 97.23 | 92.21 | 83.17 | 85.21 | 78.15 | 79.15 |
| Inventories | 6.29 | 6.41 | 7.27 | 8.90 | 8.13 | 8.80 | 10.57 |
| Trade receivables | 17.24 | 17.21 | 13.37 | 20.61 | 24.20 | 19.63 | 20.19 |
| Cash & equivalents | 0.57 | 5.01 | 8.72 | 8.87 | 9.14 | 4.28 | 4.49 |
| Total Assets | 309 | 317 | 324 | 328 | 347 | 384 | 466 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 40.82 | 42.81 | 65.69 | 65.71 | 68.71 | 66.70 | 80.69 |
| Cash from investing activity | −53.88 | −15.96 | −4.99 | 4.99 | −24.94 | −32.90 | −46.89 |
| Cash from financing activity | 12.03 | −22.06 | −57.16 | −73.16 | −48.10 | −35.06 | −31.07 |
| Net cash flow | −0.99 | 3.99 | 2.99 | −1.99 | −4.99 | 0.00 | 1.99 |
| Capex | 47.11 | 6.06 | 7.31 | 9.96 | 19.39 | 50.00 | 41.89 |
| Free cash flow | −4.99 | 37.90 | 58.81 | 57.81 | 49.83 | 17.94 | 39.88 |
| CFO / OP % | 116.0% | 88.0% | 107.0% | 103.0% | 95.0% | 101.0% | 110.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 31 | 27 | 16 | 22 | 23 | 19 | 17 |
| Inventory days | 59 | 40 | 29 | 42 | 35 | 40 | 42 |
| Days payable | 315 | 166 | 122 | 162 | 166 | 162 | 171 |
| Cash conversion cycle | −225 | −99 | −77 | −98 | −107 | −103 | −113 |
| Working capital days | −5 | 31 | 2 | −19 | −17 | −29 | −30 |
| ROCE % | — | 14.0% | 23.0% | 24.9% | 29.9% | 26.9% | 20.0% |
For the Jun 2026 quarter, GPT Healthcare reported sales of ₹125 Cr, up 17.7% year on year and net profit of ₹12.97 Cr, up 62.5% year on year. The operating margin was 18.9%.
GPT Healthcare's sales for the year to Mar 2026 were ₹471 Cr; over the last twelve months they were ₹489 Cr.
Net profit for the year to Mar 2026 was ₹41.92 Cr, and ₹47.90 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.80.
GPT Healthcare reported borrowings of ₹91.05 Cr at Mar 2026, against cash and equivalents of ₹4.49 Cr.
Cash from operations was ₹80.69 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹39.88 Cr.